The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
A critical evaluation of the Braak staging scheme for Parkinson's disease
Open accessAbstract
Braak and colleagues have proposed that, within the central nervous system, Parkinson's disease (PD) begins as a synucleinopathy in nondopaminergic structures of the lower brainstem or in the olfactory bulb. The brainstem synucleinopathy is postulated to progress rostrally to affect the substantia nigra and cause parkinsonism at a later stage of the disease. In the context of a diagnosis of PD, made from current clinical criteria, the pattern of lower brainstem involvement accompanying mesencephalic synucleinopathy is often observed. However, outside of that context, the patterns of synucleinopathy that Braak described are often not observed, particularly in dementia with Lewy bodies and when synucleinopathy occurs in the absence of neurological manifestations. The concept that lower brainstem synucleinopathy represents “early PD” rests on the supposition that it has a substantial likelihood of progressing within the human lifetime to involve the mesencephalon, and thereby cause the substantia nigra pathology and clinical parkinsonism that have heretofore defined the disease. However, the predictive validity of this concept is doubtful, based on numerous observations made in populations of aged individuals who, despite the absence of neurological signs, have brain synucleinopathy ranging up to Braak stages 4 to 6 at postmortem. Furthermore, there is no relation between Braak stage and the clinical severity of PD. We conclude that the relation between patterns of abnormal synuclein immunostaining in the human brain and the disease entity now recognized as PD remains to be determined. Ann Neurol 2008;64:485–491
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 4×
“DLB is a particular problem for the Braak scheme because such patients were excluded.(4) The exclusion of cases of DLB from the Braak series cannot be justified because there is a growing consensus that the extensive overlap in the clinical and pathological features of PD, PD with dementia, and DLB do not permit meani…”
BackgroundMethodInfluentialSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
Boeve, B. F., Silber, M. H., Saper, C. B., Ferman, T. J., Dickson, D. W., Parisi, J. E., Benarroch, E. E., Ahlskog, J. E., Smith, G. E., Caselli, R. C., et al. (2007) · Brain · doi:10.1093/brain/awm056 · Cited by 957
Olson, E. J., Boeve, B. F., & Silber, M. H. (2000) · Brain · doi:10.1093/brain/123.2.331 · Cited by 895
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
The parkinson's complex: Parkinsonism is just the tip of the iceberg
Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 583
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256715.13907.d3 · Cited by 548
REM sleep behavior disorders in multiple system atrophy
Plazzi, G., Corsini, R., Provini, F., Pierangeli, G., Martinelli, P., Montagna, P., Lugaresi, E., & Cortelli, P. (1997) · Neurology · doi:10.1212/wnl.48.4.1094 · Cited by 423
Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder
Eisensehr, I., Linke, R., Noachtar, S., Schwarz, J., Gildehaus, F. J., & Tatsch, K. (2000) · Brain · doi:10.1093/brain/123.6.1155 · Cited by 390
Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases
Gagnon, J.-F., Postuma, R. B., Mazza, S., Doyon, J., & Montplaisir, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70441-0 · Cited by 374
Parkkinen, L., Pirttilä, T., & Alafuzoff, I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0346-6 · Cited by 354
The rat brain synucleins; family of proteins transiently associated with neuronal membrane
Maroteaux, L., & Scheller, R. H. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90043-w · Cited by 334
Bloch, A., Probst, A., Bissig, H., Adams, H., & Tolnay, M. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00727.x · Cited by 330
Restoration of normal motor control in Parkinson’s disease during REM sleep
De Cock, V. C., Vidailhet, M., Leu, S., Texeira, A., Apartis, E., Elbaz, A., Roze, E., Willer, J. C., Derenne, J. P., Agid, Y., et al. (2007) · Brain · doi:10.1093/brain/awl363 · Cited by 321
Braak, H., Sastre, M., Bohl, J. R. E., de Vos, R. A. I., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0193-x · Cited by 321
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. (2005) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 315
Tompkins, M. M., Basgall, E. J., ZAMRINI, E. Y., & Hill, W. D. (1997) · Europe PMC (PubMed Central) · Cited by 314
Decreased striatal dopaminergic innervation in REM sleep behavior disorder
Albin, R. L., Koeppe, R. A., Chervin, R. D., Consens, F. B., Wernette, K., Frey, K. A., & Aldrich, M. S. (2000) · Neurology · doi:10.1212/wnl.55.9.1410 · Cited by 293
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
Patterns and stages of α-synucleinopathy: Relevance in a population-based cohort
Zaccai, J., Brayne, C., McKeith, I., Matthews, F., & Ince, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000306697.48738.b6 · Cited by 244
α-Synuclein Overexpression Protects against Paraquat-Induced Neurodegeneration
Manning-Boğ, A. B., McCormack, A. L., Purisai, M. G., Bolin, L. M., & Di Monte, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03095.2003 · Cited by 240
Eisensehr, I., Linke, R., Tatsch, K., Kharraz, B., Gildehaus, J. F., Wetter, C. T., Trenkwalder, C., Schwarz, J., & Noachtar, S. (2003) · Sleep · doi:10.1093/sleep/26.5.507 · Cited by 239
Alpha-synuclein and transgenic mouse models
Fernagut, P.-O., & Chesselet, M.-F. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.001 · Cited by 200
Lewy Body-Related α-Synucleinopathy in Aging
Saito, Y., Ruberu, N. N., Sawabe, M., Arai, T., Kazama, H., Hosoi, T., Yamanouchi, H., & Murayama, S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.742 · Cited by 200
REM sleep behaviour disorder in Parkinson?s disease: a questionnaire-based study
Scaglione, C., Vignatelli, L., Plazzi, G., Marchese, R., Negrotti, A., Rizzo, G., Lopane, G., Bassein, L., Maestri, M., Bernardini, S., et al. (2005) · Neurological Sciences · doi:10.1007/s10072-004-0364-7 · Cited by 165
Beating a dead horse: Dopamine and Parkinson disease
Ahlskog, J. E. (2007) · Neurology · doi:10.1212/01.wnl.0000296942.14309.4a · Cited by 165
Mikolaenko, I., Pletnikova, O., Kawas, C. H., O'Brien, R., Resnick, S. M., Crain, B., & Troncoso, J. C. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.156 · Cited by 159
Wakisaka, Y., Furuta, A., Tanizaki, Y., Kiyohara, Y., Iida, M., & Iwaki, T. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0750-x · Cited by 144
α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
Purisai, M. G., McCormack, A. L., Langston, J. W., Johnston, L. C., & Monte, D. A. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.028 · Cited by 142
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA
Gilman, S., Koeppe, R. A., Chervin, R. D., Consens, F. B., Little, R. J. A., An, H., Junck, L., & Heumann, M. (2003) · Neurology · doi:10.1212/01.wnl.0000073745.68744.94 · Cited by 138
Kholodilov, N. G., Neystat, M., Tinmarla, F. O., Steven, E. L., Larsen, K. E., Sulzer, D., & Burke, R. E. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732586.x · Cited by 136
Self-citationα-Synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals
Klos, K. J., Ahlskog, J. E., Josephs, K. A., Apaydın, H., Parisi, J. E., Boeve, B. F., DeLucia, M. W., & Dickson, D. W. (2006) · Neurology · doi:10.1212/01.wnl.0000204179.88955.fa · Cited by 127
Dementia with Lewy bodies and Parkinson’s disease with dementia: where two worlds collide
McKeith, I. G. (2007) · Practical Neurology · doi:10.1136/jnnp.2007.134163 · Cited by 92
Characteristics of alpha-synucleinopathy in centenarians
Ding, Z., Wang, Y., Jiang, Y., Hashizume, Y., Yoshida, M., Mimuro, M., Inagaki, T., & Iwase, T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0015-y · Cited by 57
Examining Braak's hypothesis by imaging Parkinson's disease
Brooks, D. J. (2010) · Movement Disorders · doi:10.1002/mds.22720 · Cited by 35
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Cited by
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012
Self-citationPGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease
Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang-James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 857
Prion-like transmission of protein aggregates in neurodegenerative diseases
Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778
Metadata
- Authors
- Burke, R. E., Dauer, W. T., & Vonsattel, J. P. G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-11
- Volume
- 64
- Issue
- 5
- Pages
- 485-491
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2089791510
- Cited by
- 377
- References
- 44
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.